뇌 모니터링 시장 평가 : 제품별, 처치별, 용도별, 최종 사용자별, 지역별 기회 및 예측(2018-2032년)

Global brain monitoring market is projected to witness a CAGR of 6.75% during the forecast period 2025-2032, growing from USD 6.61 billion in 2024 to USD 11.15 billion in 2032. The market demand for brain monitoring is anticipated to thrive drastically in the forecast years due to the rise in the prevalence of neurological disorders and technological advancements in brain monitoring techniques.

Brain monitoring uses varied technologies and devices that measure and analyze electrical, biochemical, and physiological activities in the brain. This process is very vital in diagnosing, managing, and researching neurological conditions such as epilepsy, brain injury, dementia, and other disorders affecting the central nervous system. Market growth for the devices used for brain monitoring is propelled by innovation, and the adoption of non-invasive monitoring techniques such as AI and machine learning for data analysis in clinical settings is also improving the utilization of these devices. Additionally, growing awareness, the rising geriatric population's increased interest in their brain health, and investment in brain monitoring research and development augment market growth. For instance, in May 2024, Christiana Care Health Services, Inc. launched an innovative electroencephalogram (EEG) brain monitoring program that enables quick, real-time diagnosis of seizures, advancing neurological care with an easy-to-use system for measuring brain electrical activity.

Increasing Prevalence of Neurological Disorders

The increasing number of neurological disorders acts as a growth driver for the global market of brain monitoring devices. The prevalence of neurological diseases like epilepsy, Alzheimer's and Parkinson's diseases, multiple sclerosis, and traumatic brain injuries is increasing due to factors like the aging population, lifestyle changes, and rising diagnostic capabilities. Neurological diseases are among the leading causes of disabilities globally, which in turn is a significant factor in demanding effective diagnostic and monitoring solutions. The growing patient population compels health service providers to look for more advanced tools, forcing industry players to continue innovating and investing. This trend is expected to support the sustained growth in the brain monitoring market.

For instance, in December 2023, Quibim, S.L. launched QP-Brain, an AI-based software for identifying early-stage neurodegenerative diseases, following FDA 510(k) clearance. With neurological diseases affecting up to one billion people globally and an aging population increasing the prevalence of these conditions, there is a growing demand for quantitative assessments to detect early brain changes.

Technological Advancements in Brain Monitoring Techniques Drive Market Growth

Technological advancements are the most significant growth drivers in the global brain monitoring market. Miniaturized device innovations, non-invasive monitoring capabilities, and data analytics are significantly expanding the applications and making these technologies more accessible. Portable, wearable brain monitoring devices enhance the possibility of continuous, real-time brain activity tracking. Furthermore, coupling artificial intelligence and machine learning has enriched these devices with better data analysis and pattern recognition, thus increasing adoption among healthcare providers. For instance, in September 2024, Neurable Inc. launched the MW75 Neuro, the first smart headphones with integrated brain-computer interface (BCI) technology, developed with New Audio LLC d/b/a Master & Dynamic. The device offers insights into cognitive health, helping manage burnout and boost daily performance.

Non-Invasive Segment to Dominate the Brain Monitoring Market

The non-invasive brain monitoring segment is anticipated to dominate the global brain monitoring market, primarily because of increasing patient-compliant and accessible diagnostics. Non-invasive technologies, such as near-infrared spectroscopy and electroencephalography (EEG), have been observed to have high efficacy with lower risk factors associated with invasive procedures, thus remaining a preferred treatment across various clinical settings. With healthcare providers focusing on safer, more efficient, and patient-compliant monitoring technologies, the market-leading segment is likely to hold its dominance in the brain monitoring market. For instance, in April 2024, Neurovigil, Inc. launched its iBrain personal brain monitor in the United States. It is an investigational portable device designed to non-invasively record brain electrical activity in individuals with neurological conditions. Initially based on electroencephalogram (EEG) technology, iBrain will also be used in the second phase to detect Parkinson's disease. The device allows efficient, at-home EEG data collection, including during sleep, providing a user-friendly solution for monitoring neurological changes.

North America Dominates Brain Monitoring Market

North America dominates the global market for brain monitoring devices, mainly due to its well-developed healthcare infrastructure, higher prevalence of neurological disorders, and strong investment in research and development. The region's aging population, coupled with increasing incidence rates of Alzheimer's disease, epilepsy, and traumatic brain injuries, stimulate demand for effective diagnostic monitoring tools. North America focuses on embracing novel technologies, especially AI-enabled devices and non-invasive monitoring solutions, and stands as the leader in terms of brain health diagnostics. Therefore, North America is expected to dominate the market primarily due to continued advances and robust demand for high-quality neurology care. For instance, in June 2024, Zeto Inc., a privately held medical technology company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its advanced electroencephalography (EEG) brain monitoring device, the Zeto ONE. Designed for use across hospital, home, ambulance, and air transport settings, including the shortage of trained EEG technologists and the need for user-friendly, comfortable devices with high signal quality. The system offers full-montage EEG, video support for enhanced interpretation, and reliable diagnostic software, fulfilling essential requirements for effective neurological care in diverse clinical environments.

Future Market Scenario (2025-2032F)

Enhanced growth in the neurological disorder population and healthcare infrastructure investments are always high across geographies, which are expected to boost the market for global brain monitoring. Emerging trends, such as AI and machine learning for a better outcome in data analysis and portable and wearable device developments, are also expected to expand the accessibility and usability of solutions for monitoring the brain in various care settings, including home-based care. The increased awareness about neurological health, particularly among aging populations, combined with the growth of healthcare budgets in developing regions, is also expected to boost market growth.

For instance, in September 2024, Brain+ A/S announced plans to expand its dementia offerings by launching three new software products in the United Kingdom by 2025 to build the world's first scalable dementia management platform. These products include At-home Cognitive Stimulation Therapy (CST) support, virtual group CST delivery, and CST Planner, following the initial release of the CST Assistant by September 2024.

Key Players Landscape and Outlook

The brain monitoring market is characterized by its dynamic landscape, shaped by the actions of numerous key players, including significant business agreements and regulatory approvals for various products. The sector has experienced a surge in strategic initiatives, encompassing mergers, acquisitions, and collaborations, reflecting a robust drive for innovation and growth within the industry.

For instance, in October 2024, Thinkie, Inc. launched a device utilizing functional Near-Infrared Spectroscopy (fNIRS) technology to measure blood flow changes in the prefrontal cortex to enhance cognitive health. The system, developed by neuroscientists, is supported by studies on cognitive training using fNIRS. Thinkie also offers a subscription for its app, which is free without the device, initially targeting senior living communities.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Brain Monitoring Market Outlook, 2018-2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Devices
      • 4.2.1.1.1. Electroencephalography (EEG) Devices
      • 4.2.1.1.2. Magnetoencephalography (MEG) Devices
      • 4.2.1.1.3. Intracranial Pressure (ICP) Monitors
      • 4.2.1.1.4. Magnetic Resonance Imaging (MRI) Devices
      • 4.2.1.1.5. Computerized Tomography (CT) Devices
      • 4.2.1.1.6. Positron Emission Tomography (PET) Devices
      • 4.2.1.1.7. Sleep Monitoring Devices
      • 4.2.1.1.8. Electromyography (EMG) Devices
      • 4.2.1.1.9. Transcranial Doppler (TCD) Devices
      • 4.2.1.1.10. Others
    • 4.2.1.2. Accessories
      • 4.2.1.2.1. Electrodes
      • 4.2.1.2.2. Sensors
      • 4.2.1.2.3. Pastes and Gels
      • 4.2.1.2.4. Caps
      • 4.2.1.2.5. Cables
      • 4.2.1.2.6. Batteries
      • 4.2.1.2.7. Others
  • 4.2.2. By Procedure
    • 4.2.2.1. Invasive
    • 4.2.2.2. Non-Invasive
  • 4.2.3. By Application
    • 4.2.3.1. Stroke
    • 4.2.3.2. Traumatic Brain Injury (TBI)
    • 4.2.3.3. Dementia
    • 4.2.3.4. Sleep Disorders
    • 4.2.3.5. Headache Disorders
    • 4.2.3.6. Epilepsy
    • 4.2.3.7. Others
  • 4.2.4. By End-user
    • 4.2.4.1. Hospitals
    • 4.2.4.2. Neurology Centers
    • 4.2.4.3. Others
  • 4.2.5. By Region
    • 4.2.5.1. North America
    • 4.2.5.2. Europe
    • 4.2.5.3. Asia-Pacific
    • 4.2.5.4. South America
    • 4.2.5.5. Middle East and Africa
  • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 4.3. Market Map Analysis, 2024
  • 4.3.1. By Product
  • 4.3.2. By Procedure
  • 4.3.3. By Application
  • 4.3.4. By End-user
  • 4.3.5. By Region

5. North America Brain Monitoring Market Outlook, 2018-2032F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product
    • 5.2.1.1. Devices
      • 5.2.1.1.1. Electroencephalography (EEG) Devices
      • 5.2.1.1.2. Magnetoencephalography (MEG) Devices
      • 5.2.1.1.3. Intracranial Pressure (ICP) Monitors
      • 5.2.1.1.4. Magnetic Resonance Imaging (MRI) Devices
      • 5.2.1.1.5. Computerized Tomography (CT) Devices
      • 5.2.1.1.6. Positron Emission Tomography (PET) Devices
      • 5.2.1.1.7. Sleep Monitoring Devices
      • 5.2.1.1.8. Electromyography (EMG) Devices
      • 5.2.1.1.9. Transcranial Doppler (TCD) Devices
      • 5.2.1.1.10. Others
    • 5.2.1.2. Accessories
      • 5.2.1.2.1. Electrodes
      • 5.2.1.2.2. Sensors
      • 5.2.1.2.3. Pastes and Gels
      • 5.2.1.2.4. Caps
      • 5.2.1.2.5. Cables
      • 5.2.1.2.6. Batteries
      • 5.2.1.2.7. Others
  • 5.2.2. By Procedure
    • 5.2.2.1. Invasive
    • 5.2.2.2. Non-Invasive
  • 5.2.3. By Application
    • 5.2.3.1. Stroke
    • 5.2.3.2. Traumatic Brain Injury (TBI)
    • 5.2.3.3. Dementia
    • 5.2.3.4. Sleep Disorders
    • 5.2.3.5. Headache Disorders
    • 5.2.3.6. Epilepsy
    • 5.2.3.7. Others
  • 5.2.4. By End-user
    • 5.2.4.1. Hospitals
    • 5.2.4.2. Neurology Centers
    • 5.2.4.3. Others
  • 5.2.5. By Country Share
    • 5.2.5.1. United States
    • 5.2.5.2. Canada
    • 5.2.5.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Brain Monitoring Market Outlook, 2018-2032F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Product
        • 5.3.1.2.1.1. Devices
        • 5.3.1.2.1.1.1. Electroencephalography (EEG) Devices
        • 5.3.1.2.1.1.2. Magnetoencephalography (MEG) Devices
        • 5.3.1.2.1.1.3. Intracranial Pressure (ICP) Monitors
        • 5.3.1.2.1.1.4. Magnetic Resonance Imaging (MRI) Devices
        • 5.3.1.2.1.1.5. Computerized Tomography (CT) Devices
        • 5.3.1.2.1.1.6. Positron Emission Tomography (PET) Devices
        • 5.3.1.2.1.1.7. Sleep Monitoring Devices
        • 5.3.1.2.1.1.8. Electromyography (EMG) Devices
        • 5.3.1.2.1.1.9. Transcranial Doppler (TCD) Devices
        • 5.3.1.2.1.1.10. Others
        • 5.3.1.2.1.2. Accessories
        • 5.3.1.2.1.2.1. Electrodes
        • 5.3.1.2.1.2.2. Sensors
        • 5.3.1.2.1.2.3. Pastes and Gels
        • 5.3.1.2.1.2.4. Caps
        • 5.3.1.2.1.2.5. Cables
        • 5.3.1.2.1.2.6. Batteries
        • 5.3.1.2.1.2.7. Others
      • 5.3.1.2.2. By Procedure
        • 5.3.1.2.2.1. Invasive
        • 5.3.1.2.2.2. Non-invasive
      • 5.3.1.2.3. By Application
        • 5.3.1.2.3.1. Stroke
        • 5.3.1.2.3.2. Traumatic Brain Injury (TBI)
        • 5.3.1.2.3.3. Dementia
        • 5.3.1.2.3.4. Sleep Disorders
        • 5.3.1.2.3.5. Headache Disorders
        • 5.3.1.2.3.6. Epilepsy
        • 5.3.1.2.3.7. Others
      • 5.3.1.2.4. By End-user
        • 5.3.1.2.4.1. Hospitals
        • 5.3.1.2.4.2. Neurology Centers
        • 5.3.1.2.4.3. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Brain Monitoring Market Outlook, 2018-2032F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Poland

7. Asia-Pacific Brain Monitoring Market Outlook, 2018-2032F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Brain Monitoring Market Outlook, 2018-2032F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Brain Monitoring Market Outlook, 2018-2032F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa
• 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

• 15.1. Market Drivers
• 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

• 17.1. Regulatory Approvals
• 17.2. Clinical Trials

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

• 20.1. Competition Matrix of Top 5 Market Leaders
• 20.2. SWOT Analysis for Top 5 Players
• 20.3. Key Players Landscape for Top 10 Market Players
  • 20.3.1. Siemens Healthineers AG
    • 20.3.1.1. Company Details
    • 20.3.1.2. Key Management Personnel
    • 20.3.1.3. Products and Services
    • 20.3.1.4. Financials (As Reported)
    • 20.3.1.5. Key Market Focus and Geographical Presence
    • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 20.3.2. Koninklijke Philips N.V.
  • 20.3.3. NIHON KOHDEN CORPORATION
  • 20.3.4. Elekta AB
  • 20.3.5. Medtronic plc
  • 20.3.6. Electrical Geodesics, Inc.
  • 20.3.7. Advanced Brain Monitoring, Inc.
  • 20.3.8. GE HealthCare Technologies Inc.
  • 20.3.9. NCC Medical Co., Ltd.
  • 20.3.10. BrainScope Company Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer